Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
J. venom. anim. toxins incl. trop. dis ; 16(4): 587-591, 2010. ilus, graf
Article Dans Anglais | LILACS, VETINDEX | ID: lil-566157

Résumé

A total of 310 blood smears were collected from sheep of the Livestock Experiment Station, Qadirabad, Sahiwal district, Pakistan, and surrounding areas. The samples were examined microscopically and 30 (9.67 percent) were positive for babesiosis. The animals were divided into two groups (A and B) for chemotherapy. Group A sheep were treated with diminazene diaceturate while group B animals received imidocarb dipropionate. Drug efficacy was determined by negative blood smear examination. Diminazene diaceturate effectiveness against babesiosis was 80 percent while that of imidocarb dipropionate was 100 percent. Hematological studies revealed a significant decrease in hemoglobin concentrations and hematocrit values for Babesia-positive animals compared to healthy controls.(AU)


Sujets)
Animaux , Babesia , Babésiose , Hémoglobines , Ovis , Préparations pharmaceutiques , Traitement médicamenteux
2.
Article Dans Anglais | LILACS, VETINDEX | ID: lil-508227

Résumé

To be granted a product license, a vaccine must present adequate quality, safety and efficacy. Studies on these criteria often utilize target species in a laboratory setting. Vaccines that had been proven effective during laboratory analysis may not present the same features when sold on a large scale, after encountering field conditions, and furthermore, can even produce complications. Measures are already in place to detect adverse reactions as reported by veterinarians to manufacturers, so that vaccines under suspicion of failing can be identified and investigated. The present review article describes the main problems, specifically adverse reactions and lack of efficacy, that have been encountered following release of vaccines for general use.(AU)


Sujets)
Risque , Vaccination , Management par la qualité , Vaccins , Efficacité en Santé Publique
SÉLECTION CITATIONS
Détails de la recherche